BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 30309460)

  • 21. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [PATHOPHYSIOLOGY OF THE CARDIORENAL SYNDROME].
    Balint I; Vučak J; Bašić-Marković N; Klarić D; Šakić VA
    Acta Med Croatica; 2016 Dec; 70(4-5):325-31. PubMed ID: 29087629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of Loop Diuretic on Outcomes in Patients with Heart Failure and Reduced Ejection Fraction.
    Antonietta CM; Calvi E; Faggiano A; Maffeis C; Bosisio M; De Stefano M; Carugo S; Faggiano P
    Curr Heart Fail Rep; 2022 Feb; 19(1):15-25. PubMed ID: 35037162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diuretic therapy in heart failure].
    Trullàs JC; Morales-Rull JL; Formiga F;
    Med Clin (Barc); 2014 Feb; 142(4):163-70. PubMed ID: 23768854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diuretic Therapy for Patients With Heart Failure: JACC State-of-the-Art Review.
    Felker GM; Ellison DH; Mullens W; Cox ZL; Testani JM
    J Am Coll Cardiol; 2020 Mar; 75(10):1178-1195. PubMed ID: 32164892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diuretic therapy in acute heart failure].
    Trullàs JC; Morales-Rull JL; Formiga F
    Med Clin (Barc); 2014 Mar; 142 Suppl 1():36-41. PubMed ID: 24930082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Clinical Approach to the Acute Cardiorenal Syndrome.
    Jentzer JC; Chawla LS
    Crit Care Clin; 2015 Oct; 31(4):685-703. PubMed ID: 26410138
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute decompensated heart failure and the cardiorenal syndrome.
    Liang KV; Williams AW; Greene EL; Redfield MM
    Crit Care Med; 2008 Jan; 36(1 Suppl):S75-88. PubMed ID: 18158481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Continuation of Chronic Heart Failure Therapies During Heart Failure Hospitalization - a Review.
    Singhania G; Ejaz AA; McCullough PA; Kluger AY; Balamuthusamy S; Dass B; Singhania N; Agarwal A
    Rev Cardiovasc Med; 2019 Sep; 20(3):111-120. PubMed ID: 31601085
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diuretics in States of Volume Overload: Core Curriculum 2022.
    Novak JE; Ellison DH
    Am J Kidney Dis; 2022 Aug; 80(2):264-276. PubMed ID: 35190215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diuretic response in acute heart failure-pathophysiology, evaluation, and therapy.
    ter Maaten JM; Valente MA; Damman K; Hillege HL; Navis G; Voors AA
    Nat Rev Cardiol; 2015 Mar; 12(3):184-92. PubMed ID: 25560378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Loop diuretics for chronic heart failure: a foe in disguise of a friend?
    Kapelios CJ; Malliaras K; Kaldara E; Vakrou S; Nanas JN
    Eur Heart J Cardiovasc Pharmacother; 2018 Jan; 4(1):54-63. PubMed ID: 28633477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diuretics and ultrafiltration in acute decompensated heart failure.
    Felker GM; Mentz RJ
    J Am Coll Cardiol; 2012 Jun; 59(24):2145-53. PubMed ID: 22676934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decongestive treatment of acute decompensated heart failure: cardiorenal implications of ultrafiltration and diuretics.
    Freda BJ; Slawsky M; Mallidi J; Braden GL
    Am J Kidney Dis; 2011 Dec; 58(6):1005-17. PubMed ID: 22014726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination Diuretic Therapy to Counter Renal Sodium Avidity in Acute Heart Failure: Trials and Tribulations.
    Kazory A
    Clin J Am Soc Nephrol; 2023 Oct; 18(10):1372-1381. PubMed ID: 37102974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiorenal interactions in acute decompensated heart failure: contemporary concepts facing emerging controversies.
    Kazory A; Elkayam U
    J Card Fail; 2014 Dec; 20(12):1004-11. PubMed ID: 25230240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel strategies: challenge loop diuretics and sodium management in heart failure--Part I.
    Pasquale PD; Sarullo FM; Paterna S
    Congest Heart Fail; 2007; 13(2):93-8. PubMed ID: 17392613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Administration of tolvaptan with reduction of loop diuretics ameliorates congestion with improving renal dysfunction in patients with congestive heart failure and renal dysfunction.
    Hanatani A; Shibata A; Kitada R; Iwata S; Matsumura Y; Doi A; Sugioka K; Takagi M; Yoshiyama M
    Heart Vessels; 2017 Mar; 32(3):287-294. PubMed ID: 27385022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toward Precision Medicine in the Cardiorenal Syndrome.
    Wettersten N; Maisel AS; Cruz DN
    Adv Chronic Kidney Dis; 2018 Sep; 25(5):418-424. PubMed ID: 30309459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diuretic-resistant heart failure and the role of ultrafiltration: A proposed protocol.
    Gomes da Silva F; Calça R; Rita Martins A; Araújo I; Aguiar C; Fonseca C; Branco P
    Rev Port Cardiol; 2023 Sep; 42(9):797-803. PubMed ID: 36948455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.